These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19472336)

  • 1. Listeriolysin O as cytotoxic component of an immunotoxin.
    Bergelt S; Frost S; Lilie H
    Protein Sci; 2009 Jun; 18(6):1210-20. PubMed ID: 19472336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Listeriolysin o is strongly immunogenic independently of its cytotoxic activity.
    Carrero JA; Vivanco-Cid H; Unanue ER
    PLoS One; 2012; 7(3):e32310. PubMed ID: 22403645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
    Peng X; Treml J; Paterson Y
    Cancer Immunol Immunother; 2007 Jun; 56(6):797-806. PubMed ID: 17102978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perparation and characterization of the monoclonal antibodies against listeriolysin O].
    Dong H; Jiao XA; Yin YL; Pan ZM; Huang JL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):240-2. PubMed ID: 18328183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of neutralizing and nonneutralizing monoclonal antibodies against listeriolysin O.
    Nato F; Reich K; Lhopital S; Rouyre S; Geoffroy C; Mazie JC; Cossart P
    Infect Immun; 1991 Dec; 59(12):4641-6. PubMed ID: 1937824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prokaryotic expression of Listeria monocytogenes (LM) hly and development of monoclonal antibodies against listeriolysin O (LLO)].
    Luo Z; Liu R; Zheng S
    Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1652-7. PubMed ID: 20222463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects of listeriolysin O: implications for vaccination.
    Hernández-Flores KG; Vivanco-Cid H
    Biomed Res Int; 2015; 2015():360741. PubMed ID: 25874208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Listeriolysin O, a cytolysin derived from Listeria monocytogenes, inhibits generation of ovalbumin-specific Th2 immune response by skewing maturation of antigen-specific T cells into Th1 cells.
    Yamamoto K; Kawamura I; Tominaga T; Nomura T; Kohda C; Ito J; Mitsuyama M
    Clin Exp Immunol; 2005 Nov; 142(2):268-74. PubMed ID: 16232213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel membrane-acting immunotoxin, the immunolysin, with therapeutic potential.
    Drobniewski FA; Watson GJ; Wawrzynczak EJ; Alouf JE; Thorpe PE
    Biochem Soc Trans; 1992 Nov; 20(4):318S. PubMed ID: 1486988
    [No Abstract]   [Full Text] [Related]  

  • 10. Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity.
    Andrews CD; Huh MS; Patton K; Higgins D; Van Nest G; Ott G; Lee KD
    Mol Pharm; 2012 May; 9(5):1118-25. PubMed ID: 22376145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH dependence of listeriolysin O aggregation and pore-forming ability.
    Bavdek A; Kostanjšek R; Antonini V; Lakey JH; Dalla Serra M; Gilbert RJ; Anderluh G
    FEBS J; 2012 Jan; 279(1):126-41. PubMed ID: 22023160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeting of a pore-forming toxin (listeriolysin O) to LHRH-positive cancer cells using LHRH targeting peptide.
    Kheirandish MH; Jaliani HZ; Rahmani B; Nikukar H
    Toxicon; 2019 Jun; 164():82-86. PubMed ID: 30991063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the safety and adjuvant effect of a detoxified listeriolysin O mutant on the humoral response to dengue virus antigens.
    Hernández-Flores KG; Calderón-Garcidueñas AL; Mellado-Sánchez G; Ruiz-Ramos R; Sánchez-Vargas LA; Thomas-Dupont P; Izaguirre-Hernández IY; Téllez-Sosa J; Martínez-Barnetche J; Wood L; Paterson Y; Cedillo-Barrón L; López-Franco O; Vivanco-Cid H
    Clin Exp Immunol; 2017 Apr; 188(1):109-126. PubMed ID: 27886660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Listeriolysin O potentiates immunotoxin and bleomycin cytotoxicity.
    Kerr DE; Wu GY; Wu CH; Senter PD
    Bioconjug Chem; 1997; 8(6):781-4. PubMed ID: 9404648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of the listeriolysin O-directed immune response by conservative alteration of the immunodominant listeriolysin O amino acid 91 to 99 epitope.
    Bouwer HG; Moors M; Hinrichs DJ
    Infect Immun; 1996 Sep; 64(9):3728-35. PubMed ID: 8751922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of listeriolysin O pH dependence.
    Schuerch DW; Wilson-Kubalek EM; Tweten RK
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12537-42. PubMed ID: 16105950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.
    Kim NH; Provoda C; Lee KD
    Mol Pharm; 2015 Feb; 12(2):342-50. PubMed ID: 25521817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of heterogeneous nuclear ribonucleoprotein M with listeriolysin O induces type I interferon expression and restricts Listeria monocytogenes growth in host cells.
    Luo Z; Li Z; Chen K; Liu R; Li X; Cao H; Zheng SJ
    Immunobiology; 2012 Oct; 217(10):972-81. PubMed ID: 22317749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants.
    Bouwer HG; Gibbins BL; Jones S; Hinrichs DJ
    Infect Immun; 1994 Mar; 62(3):1039-45. PubMed ID: 7509313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses.
    Huang JM; La Ragione RM; Cooley WA; Todryk S; Cutting SM
    Vaccine; 2008 Nov; 26(48):6043-52. PubMed ID: 18809450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.